Kadimastem Ltd. Logo

Kadimastem Ltd.

Develops off-the-shelf stem cell therapies for diabetes & neurodegenerative diseases.

KDST | TA

Overview

Corporate Details

ISIN(s):
IL0011284614
LEI:
Country:
Israel
Address:
Pinchas Sapir 3, Weizmann Science Park, 7414003 Nes-Ziona
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Kadimastem Ltd. is a clinical-stage biotechnology company specializing in the development of regenerative medicine and cell therapies. The company leverages a proprietary technology platform for the industrial development and manufacturing of "off-the-shelf," allogeneic cell products derived from human embryonic stem cells. These therapies are designed for broad patient application to treat debilitating diseases, with a focus on conditions such as diabetes and neurodegenerative disorders. Kadimastem's approach aims to provide commercially viable, readily available treatments by creating universal cell-based products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-05-28 11:41
Investor Presentation
Company Presentation
English 4.4 MB
2024-05-28 11:41
Pre-Annual General Meeting Information
Company Presentation
Russian 42.5 KB
2024-02-12 13:47
Regulatory News Service
Excellence Investments Management and Securities will cease to operate as a mar…
Hebrew (modern) 122.7 KB
2022-12-13 16:05
Regulatory News Service
Rights Offering and Identifying Details for New Security-KADIMASTEM R4
Hebrew (modern) 177.9 KB
2022-08-09 13:00
Regulatory News Service
Kadimastem Receives US Patent For Amyotrophic Lateral Sclerosis (ALS) Treatment
English 12.0 KB
2022-06-08 13:00
Regulatory News Service
Kadimastem and Implant Therapeutics, Inc. Sign an Evaluation Agreement Towards …
English 12.1 KB
2022-05-30 15:10
Regulatory News Service
Kadimastem Awarded Patent in Japan for AstroRx For ALS and Drug Screening
English 10.6 KB
2022-05-18 13:00
Regulatory News Service
Kadimastem Expands R&D Program to Include Multiple Sclerosis
English 9.5 KB
2022-03-03 14:05
Regulatory News Service
Kadimastem Receives Grant for a Total Budget of NIS 10 Million ($3.1 million) f…
English 10.4 KB
2021-12-13 13:00
Capital/Financing Update
Kadimastem Announces the Approval of a 4M NIS ($1.29M) Budget from the Israel I…
English 10.6 KB
2021-10-26 07:49
Share Issue/Capital Change
Kadimastem Raises $5 million In Private Placement
English 10.5 KB
2021-10-25 14:09
Share Issue/Capital Change
Kadimastem Raises NIS 16.1 million ($5 million) In Private Placement
English 10.5 KB
2021-10-12 15:55
Legal Proceedings Report
Kadimastem Holds Successful Preliminary Meeting with the FDA (INTERACT) Regar…
English 9.5 KB
2021-05-02 19:15
Investor Presentation
Company Presentation May 2021
English 3.0 MB
2021-05-02 19:15
Report Publication Announcement
Company Presentation May 2021
Russian 42.5 KB

Automate Your Workflow. Get a real-time feed of all Kadimastem Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Kadimastem Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
ADBIOTECH Co.,Ltd. Logo
Develops egg-based IgY antibodies as vaccine/antibiotic alternatives for animal and human health.
South Korea 179530
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Develops user-friendly, saliva-based tests for health monitoring & therapeutic drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics, managing the full value chain from R&D to sales.
Japan 2927
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK
Alkaloid AD Logo
Manufactures pharmaceuticals, cosmetics, and herbal products for professionals and consumers.
North Macedonia ALK
ALLERGY THERAPEUTICS PLC Logo
Develops innovative, aluminum-free allergy immunotherapy vaccines for the European market.
United Kingdom AGY
Alligator Bioscience Logo
Develops immuno-oncology antibody drugs to activate the immune system against hard-to-treat cancers.
Sweden ATORX

Talk to a Data Expert

Have a question? We'll get back to you promptly.